The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 13, Issue 593, Pages eabf1906
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-04-06
DOI
10.1126/scitranslmed.abf1906
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020
- (2021) Kathy Leung et al. Eurosurveillance
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- A human neutralizing antibody targets the receptor binding site of SARS-CoV-2
- (2020) Rui Shi et al. NATURE
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- Developing therapeutic monoclonal antibodies at pandemic pace
- (2020) Brian Kelley NATURE BIOTECHNOLOGY
- If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future
- (2020) Martin McKee et al. NATURE MEDICINE
- SARS-CoV-2 infection protects against rechallenge in rhesus macaques
- (2020) Abishek Chandrashekar et al. SCIENCE
- DNA vaccine protection against SARS-CoV-2 in rhesus macaques
- (2020) Jingyou Yu et al. SCIENCE
- Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
- (2020) Barry Rockx et al. SCIENCE
- Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
- (2020) Jiandong Huo et al. Cell Host & Microbe
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
- (2020) Lihong Liu et al. NATURE
- Potently neutralizing and protective human antibodies against SARS-CoV-2
- (2020) Seth J. Zost et al. NATURE
- Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
- (2020) Seth J. Zost et al. NATURE MEDICINE
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
- (2020) Ching-Lin Hsieh et al. SCIENCE
- Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
- (2020) Shibo Jiang et al. TRENDS IN IMMUNOLOGY
- Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics
- (2020) Pavlo Gilchuk et al. Nature Biomedical Engineering
- Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion
- (2020) Donald J. Benton et al. NATURE
- Rapid and robust antibody Fab fragment crystallization utilizing edge-to-edge beta-sheet packing
- (2020) Ricky Lieu et al. PLoS One
- REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
- (2020) Alina Baum et al. SCIENCE
- SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
- (2020) Peter Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Penetration of a Monoclonal Antibody Combination (ASN100) Targeting S. aureus Cytotoxins in Lung Epithelial Lining Fluid: A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study in Healthy Volunteers.
- (2019) Zoltan Magyarics et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix
- (2019) Dorothee Liebschner et al. Acta Crystallographica Section D-Structural Biology
- A Decoupled Automation Platform for Hydrogen/Deuterium Exchange Mass Spectrometry Experiments
- (2019) Alfonso Espada et al. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
- DECA, A Comprehensive, Automatic Post-processing Program for HDX-MS Data
- (2019) Ryan J. Lumpkin et al. MOLECULAR & CELLULAR PROTEOMICS
- Real-time cryo-electron microscopy data preprocessing with Warp
- (2019) Dimitry Tegunov et al. NATURE METHODS
- A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
- (2019) Sabue Mulangu et al. NEW ENGLAND JOURNAL OF MEDICINE
- cisTEM, user-friendly software for single-particle image processing
- (2018) Timothy Grant et al. eLife
- ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps
- (2018) Tristan Ian Croll Acta Crystallographica Section D-Structural Biology
- cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
- (2017) Ali Punjani et al. NATURE METHODS
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
- (2017) Timothy P. Sheahan et al. Science Translational Medicine
- Generation of stable Chinese hamster ovary pools yielding antibody titers of up to 7.6 g/L using the piggyBac transposon system
- (2016) Yashas Rajendra et al. BIOTECHNOLOGY PROGRESS
- Structural and molecular basis for Ebola virus neutralization by protective human antibodies
- (2016) J. Misasi et al. SCIENCE
- Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?
- (2015) Mireia Pelegrin et al. TRENDS IN MICROBIOLOGY
- Feature Selection with theBorutaPackage
- (2015) Miron B. Kursa et al. Journal of Statistical Software
- Dose-Response Analysis Using R
- (2015) Christian Ritz et al. PLoS One
- High-throughput mAb expression and purification platform based on transient CHO
- (2014) Gavin C. Barnard et al. BIOTECHNOLOGY PROGRESS
- How good are my data and what is the resolution?
- (2013) Philip R. Evans et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Data processing and analysis with theautoPROCtoolbox
- (2011) Clemens Vonrhein et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Quantitative Prediction of Human Pharmacokinetics for Monoclonal Antibodies
- (2011) Jennifer Q. Dong et al. CLINICAL PHARMACOKINETICS
- Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data
- (2011) Rong Deng et al. mAbs
- High-throughput analysis of single hematopoietic stem cell proliferation in microfluidic cell culture arrays
- (2011) Véronique Lecault et al. NATURE METHODS
- Integration, scaling, space-group assignment and post-refinement
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Pharmacokinetics-Pharmacodynamics of a Respiratory Syncytial Virus Fusion Inhibitor in the Cotton Rat Model
- (2010) M.-C. Rouan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nonhuman Primate Models of Human Immunology
- (2010) Ilhem Messaoudi et al. ANTIOXIDANTS & REDOX SIGNALING
- Chemical synthesis of the mouse mitochondrial genome
- (2010) Daniel G Gibson et al. NATURE METHODS
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started